Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Distinct cell adhesion signature defines glioblastoma myeloid-derived suppressor cell subsets

ABSTRACT: Distinct cell adhesion signature defines glioblastoma myeloid-derived suppressor cell subsets

PROVIDER: PRJNA851367 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Distinct cell adhesion signature defines glioblastoma myeloid-derived suppressor cell subsets

Project description:Increased myeloid-derived suppressor cell (MDSC) frequency is associated with worse outcomes and poor therapeutic response in multiple types of cancer. In the glioblastoma (GBM) microenvironment, monocytic (m) MDSCs represent the predominant subset. However, the molecular basis of mMDSC enrichment in the tumor microenvironment compared to granulocytic (g) MDSCs has yet to be determined. Here we performed first broad epigenetic profiling of MDSC subsets to define underlying cell-intrinsic differences in their behavior and found that mMDSCs and gMDSCs display differences in their tumor-accelerating ability, with mMDSCs driving tumor growth in GBM models. Epigenetic assessments revealed enhanced gene accessibility for cell adhesion programs in mMDSCs and higher integrin b1 expression and function in mouse and human mMDSCs. Integrin b1 blockage abrogated the tumor-promoting phenotype of mMDSCs and altered the immune profile in the tumor microenvironment. These findings suggest that integrin b1 expression underlies the enrichment of mMDSCs in tumors and represents a putative immunotherapy target to attenuate myeloid cell-driven immune suppression in GBM.

2022-06-26 | GSE206551 | GEO

Myeloid-derived suppressor cell subsets drive glioblastoma growth in a sex-specific manner

Project description:Myeloid-derived suppressor cell subsets drive glioblastoma growth in a sex-specific manner

| PRJNA624324 | ENA

Arg1 expression defines immunosuppressive subsets of immune infiltrating cells in cancer

Project description:Arg1 expression defines immunosuppressive subsets of immune infiltrating cells in cancer

| PRJNA449347 | ENA

Myeloid-Derived Suppressor Cell Subsets Drive Glioblastoma Growth in a Sex-Specific Manner.

Project description: Not available

| S-EPMC7415660 | biostudies-literature

Expression data from healthy human PB B cell subsets

Project description:Human PB B cell subsets are functionally distinct and may derive from different developmental pathways, reflected by their differential gene expression profiles. We used microarrays to detail the global programme of gene expression underlying germinal center transition and functional propensities of individual subsets according to surface receptor and cell adhesion molecule expression. Human PB B cell subsets were sort-purified, RNA was extracted and processed. Data were vsn-normalized, corrected for batch-effects (ComBat) and analysed with GeneSpring GX7.

2014-12-11 | E-GEOD-64028 | biostudies-arrayexpress

Arg1 expression defines immunosuppressive subsets of immune infiltrating cells in cancer

Project description:Tumor-associated macrophages (TAM) have attracted attention as they can modulate key cancer-related activities, yet TAM represent a heterogenous group of cells that remain incompletely characterized. In growing tumors, TAM are often referred to as M2-like macrophages, which are cells that display immunosuppressive and tumorigenic functions and express the enzyme arginase 1 (Arg1). Here we combined single cell intravital imaging with scRNA seq to uncover the topography and molecular profiles of Arg1+ macrophages in mice. We further assessed how immunotherapeutic interventions impact these cells directly in vivo. We show that: i) Arg1+ macrophages are more abundant in tumors compared to other organs; ii) there exist two morphologically distinct subsets of Arg1 TAM defined by previously unknown markers (Gbp2b, Bst1, Sgk1, Pmepa1, Ms4a7); iii) anti-Programmed Cell Death-1 (aPD-1) therapy decreases the number of Arg1+ TAM while increasing Arg1– TAM; iv) accordingly, pharmacological inhibition of arginase 1 does not synergize with aPD-1 therapy. Overall, this research defines subsets of immunosuppressive myeloid cells with powerful complementary single cell analytical approaches that pave the way for a more intricate understanding of TAM behavior.

2018-12-11 | GSE112865 | GEO

Expression of different members of the Ly-49 gene family defines distinct natural killer cell subsets and cell adhesion properties.

Project description: Not available

| S-EPMC2191804 | biostudies-other

Expression data from healthy human PB B cell subsets

2014-12-11 | GSE64028 | GEO

Proteomics of human dendritic cell subsets

Project description:We exploited label-free quantitative mass spectrometry to compare primary human blood Dendritic cells (DCs) subsets protein expression to identify new markers. Subsets distinguished are: Plasmacytoid DCs (pDC) and BDCA3+ and CD1c+ myeloid DCs and CD16+ monocytes. The dendritic cells were analyzed by LC-MS/MS and processed by MaxQuant for identification and LFQ quantification.

2016-09-27 | PXD004678 | Pride

CD94 defines phenotypically and functionally distinct mouse NK cell subsets.

Project description: Not available

| S-EPMC2924742 | biostudies-literature